Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-09

Clinical Trial Update: Cerebrolysin as an Add-On Therapy to Standard Treatment of Basilar Artery Occlusion [EARLY_Phase 1]

View source ↗

Summary

Cerebrolysin is being studied as an add-on therapy to standard treatment for basilar artery occlusion in an early phase 1 trial; the study is not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cerebrolysin

Snippet

Sponsor: University Hospital Sestre Milosrdnice | Conditions: Basilar Artery Occlusion, Posterior Circulation Brain Infarction | EARLY_Phase 1 | Status: NOT_YET_RECRUITING